Skip to main content
Top
Published in: Endocrine 3/2019

01-03-2019 | Original Article

18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer

Authors: Domenico Albano, Rexhep Durmo, Francesco Bertagna, Raffaele Giubbini

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Purpose

Thyroid incidental uptake is defined as a thyroid uptake incidentally detected by imaging examinations performed for non-thyroid disease. The aim of this study was to establish the prevalence and the pathological nature of focal thyroid incidental uptake (FTIU) among patients studied with 18F-choline-PET/CT.

Materials and methods

We retrospectively evaluated 368 patients who performed 18F-choline-PET/CT between June 2016 and August 2018. The PET images were analyzed visually and semi-quantitatively by measuring the maximum standardized uptake value (SUVmax) and the mean SUV (SUVmean) of the thyroid gland and of the FTIU; every focal thyroid uptake deviating from physiological distribution and background was considered FTIU. Final diagnosis of FTIU was obtained by cytological or histological examination after surgery.

Results

The average SUVmax and SUVmean of thyroid gland in population were 3 and 1.8. Among 368 patients, FTIU was identified in nine cases (2.4%) and eight underwent further investigations to determine the nature. Two FTIU were classified as malignant (thyroid carcinoma), whereas five were benign (three nodular hyperplasia, one follicular adenoma, one Hurtle cell adenoma) and one indeterminate at cytological examination. In malignant lesions, average SUVmax was 9.6 and 4.5, respectively, while average SUVmean was 5.3 and 2.9, respectively. Average SUVmax and SUVmean of benign lesions were 4.9 and 3.2 and of the indeterminate lesion 5 and 3, respectively.

Conclusions

18F-choline-PET/CT FTIU may be a relevant diagnostic reality, which requires further investigations and affects management, especially considering that, despite being mainly benign, also malignancy is possible.
Literature
1.
go back to reference B. Burguera, H. Gharib, Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol. Metab. Clin. N. Am. 29, 187–203 (2000)CrossRef B. Burguera, H. Gharib, Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol. Metab. Clin. N. Am. 29, 187–203 (2000)CrossRef
2.
go back to reference N.G. Iyer, A.R. Shaha, C.E. Silver, K.O. Devaney, A. Rinaldo, P.K. Pellitteri et al. Thyroid incidentalomas: to treat or not to treat. Eur. Arch. Otorhinolaryngol. 267, 1019–1026 (2010)CrossRefPubMed N.G. Iyer, A.R. Shaha, C.E. Silver, K.O. Devaney, A. Rinaldo, P.K. Pellitteri et al. Thyroid incidentalomas: to treat or not to treat. Eur. Arch. Otorhinolaryngol. 267, 1019–1026 (2010)CrossRefPubMed
3.
go back to reference A. Tamburello, G. Treglia, D. Albano, F. Bertagna, L. Giovanella, Prevalence and clinical significance of focal incidental 18F-FDG uptake in different organs: an evidence-based summary. Clin. Transl. Imaging 5, 525 (2017)CrossRef A. Tamburello, G. Treglia, D. Albano, F. Bertagna, L. Giovanella, Prevalence and clinical significance of focal incidental 18F-FDG uptake in different organs: an evidence-based summary. Clin. Transl. Imaging 5, 525 (2017)CrossRef
4.
go back to reference M. Salvatori, L. Melis, P. Castaldi, M.L. Maussier, V. Rufini, G. Perotti et al. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed. Pharmacother. 61, 488–493 (2007)CrossRefPubMed M. Salvatori, L. Melis, P. Castaldi, M.L. Maussier, V. Rufini, G. Perotti et al. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Biomed. Pharmacother. 61, 488–493 (2007)CrossRefPubMed
5.
go back to reference H.B. Wu, Q.S. Wang, M.F. Wang, H.S. Li, Utility of 11C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma. Clin. Nucl. Med. 36, 91–95 (2011)CrossRefPubMed H.B. Wu, Q.S. Wang, M.F. Wang, H.S. Li, Utility of 11C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma. Clin. Nucl. Med. 36, 91–95 (2011)CrossRefPubMed
6.
go back to reference A. Eccles, A. Challapalli, S. Khan, T. Barwick, S. Mangar, Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT. Clin. Nucl. Med. 38, 755–757 (2013)CrossRefPubMed A. Eccles, A. Challapalli, S. Khan, T. Barwick, S. Mangar, Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT. Clin. Nucl. Med. 38, 755–757 (2013)CrossRefPubMed
7.
go back to reference G. Paone, G. Treglia, M. Bongiovanni, T. Roberto, L. Ceriani, L. Giovanella, Incidental detection of Hurtle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer. Rev. Esp. Med Nucl. Imagen Mol. 32, 340–341 (2013)PubMed G. Paone, G. Treglia, M. Bongiovanni, T. Roberto, L. Ceriani, L. Giovanella, Incidental detection of Hurtle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer. Rev. Esp. Med Nucl. Imagen Mol. 32, 340–341 (2013)PubMed
8.
go back to reference G. Treglia, E. Giovannini, P. Mirk, D. Di Franco, L. Oragano, F. Bertagna, A thyroid incidentaloma detected by 18F-choline PET/CT. Clin. Nucl. Med. 39, e267–e269 (2014)CrossRefPubMed G. Treglia, E. Giovannini, P. Mirk, D. Di Franco, L. Oragano, F. Bertagna, A thyroid incidentaloma detected by 18F-choline PET/CT. Clin. Nucl. Med. 39, e267–e269 (2014)CrossRefPubMed
9.
go back to reference M. Hodolic, V. Huchet, S. Balogova, L. Michaud, K. Kerrou, V. Nataf et al. Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol. Oncol. 48, 228–234 (2014)CrossRefPubMedPubMedCentral M. Hodolic, V. Huchet, S. Balogova, L. Michaud, K. Kerrou, V. Nataf et al. Incidental uptake of 18F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol. Oncol. 48, 228–234 (2014)CrossRefPubMedPubMedCentral
10.
go back to reference A.L. Aziz, F. Courbon, L.O. Diericks, P. Pascal, S. Zerdoud, Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET/CT. J. Nucl. Med. Technol. 43, 133–134 (2015)CrossRefPubMed A.L. Aziz, F. Courbon, L.O. Diericks, P. Pascal, S. Zerdoud, Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET/CT. J. Nucl. Med. Technol. 43, 133–134 (2015)CrossRefPubMed
11.
go back to reference A.M. Garcia Vicente, A. Nunez Garcia, A.M. Soriano Castrejon, G.A. Jimenez Londono, J.M. Cordero Garcia, A. Palomar Munoz, Pitfalls with 18F-choline PET/CT in patients with prostate cancer. Rev. Esp. Med Nucl. Imagen Mol. 32, 37–39 (2013)PubMed A.M. Garcia Vicente, A. Nunez Garcia, A.M. Soriano Castrejon, G.A. Jimenez Londono, J.M. Cordero Garcia, A. Palomar Munoz, Pitfalls with 18F-choline PET/CT in patients with prostate cancer. Rev. Esp. Med Nucl. Imagen Mol. 32, 37–39 (2013)PubMed
12.
go back to reference P. Lalire, M. Zalzali, C. Garbar, C. Bruna-Muraille, D. Morland, Incidental detection of oxifilic papillary thyroid carcinoma by 18F-fluorocholine PET/CT. Clin. Nucl. Med. 41, 512–513 (2016)CrossRefPubMed P. Lalire, M. Zalzali, C. Garbar, C. Bruna-Muraille, D. Morland, Incidental detection of oxifilic papillary thyroid carcinoma by 18F-fluorocholine PET/CT. Clin. Nucl. Med. 41, 512–513 (2016)CrossRefPubMed
13.
go back to reference A. Outtara, T. Ribeiro de Oliveira, S. Holz, H. Van den Bossche, D. Strybol, C. Assenmacher et al. Incidental detection of occult thyroid carcinoma with 11C-choline PET/CT for high risk prostate cancer. Curr. Urol. 10, 217–220 (2016)CrossRef A. Outtara, T. Ribeiro de Oliveira, S. Holz, H. Van den Bossche, D. Strybol, C. Assenmacher et al. Incidental detection of occult thyroid carcinoma with 11C-choline PET/CT for high risk prostate cancer. Curr. Urol. 10, 217–220 (2016)CrossRef
14.
go back to reference N.T.K. Thanseer, S.K. Bhadada, A. Sood, A.S. Parihar, D. Dahiya, P. Singh et al. Dual pathologies of parathyroid adenoma and papillary thyroid cancer on fluorocholine and fluorodeoxyglucose PET/CT. Nucl. Med. Mol. Imaging 52, 154–158 (2018)CrossRefPubMed N.T.K. Thanseer, S.K. Bhadada, A. Sood, A.S. Parihar, D. Dahiya, P. Singh et al. Dual pathologies of parathyroid adenoma and papillary thyroid cancer on fluorocholine and fluorodeoxyglucose PET/CT. Nucl. Med. Mol. Imaging 52, 154–158 (2018)CrossRefPubMed
16.
go back to reference M. Beheshti, A. Haroon, J.B. Bomanji, W. Langsteger, Fluorocholine PET/computed tomography. Physiologic uptake, bening findings, and pitfalls. Pet. Clin. 9, 299–306 (2014)CrossRefPubMed M. Beheshti, A. Haroon, J.B. Bomanji, W. Langsteger, Fluorocholine PET/computed tomography. Physiologic uptake, bening findings, and pitfalls. Pet. Clin. 9, 299–306 (2014)CrossRefPubMed
17.
go back to reference A. Haroon, L. Zanoni, M. Celli, R. Zakavi, M. Beheshti, W. Langsteger et al. Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants. Nucl. Med Comm. 36, 1065–1075 (2015)CrossRef A. Haroon, L. Zanoni, M. Celli, R. Zakavi, M. Beheshti, W. Langsteger et al. Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants. Nucl. Med Comm. 36, 1065–1075 (2015)CrossRef
18.
go back to reference N. Khan, N. Oriuchi, H. Ninomiya, T. Higuchi, H. Kamada, K. Endo, Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Ann. Nucl. Med. 18, 409–417 (2004)CrossRefPubMed N. Khan, N. Oriuchi, H. Ninomiya, T. Higuchi, H. Kamada, K. Endo, Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Ann. Nucl. Med. 18, 409–417 (2004)CrossRefPubMed
19.
go back to reference T. Torizuka, T. Kanno, M. Futatsubashi, H. Okada, E. Yoshikawa, F. Nakamura et al. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J. Nucl. Med. 44, 1051–1056 (2003)PubMed T. Torizuka, T. Kanno, M. Futatsubashi, H. Okada, E. Yoshikawa, F. Nakamura et al. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J. Nucl. Med. 44, 1051–1056 (2003)PubMed
20.
go back to reference T. Yanagawa, H. Watanabe, T. Inoue, A.R. Ahmed, K. Tomiyoshi, T. Shinozaki et al. Carbon-11 choline positron emission tomography in musculoskeletal tumours: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J. Comput. Assist. Tomogr. 27, 175–182 (2003)CrossRefPubMed T. Yanagawa, H. Watanabe, T. Inoue, A.R. Ahmed, K. Tomiyoshi, T. Shinozaki et al. Carbon-11 choline positron emission tomography in musculoskeletal tumours: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J. Comput. Assist. Tomogr. 27, 175–182 (2003)CrossRefPubMed
21.
go back to reference A. Piccardo, P. Trimboli, M. Rutigliani, M. Puntoni, L. Foppiani, L. Bacigalupo et al. Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging (2018). https://doi.org/10.1007/s00259-018-4147-4 A. Piccardo, P. Trimboli, M. Rutigliani, M. Puntoni, L. Foppiani, L. Bacigalupo et al. Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging (2018). https://​doi.​org/​10.​1007/​s00259-018-4147-4
23.
go back to reference C. Welle, E.L. Cullen, P.J. Peller, V.J. Lowe, R.C. Murphy, G.B. Johnson et al. 11C-choline PET/CT in recurrent prostate cancer and nonprostatic neoplastic processes. Radiographics 36, 279–292 (2016)CrossRefPubMed C. Welle, E.L. Cullen, P.J. Peller, V.J. Lowe, R.C. Murphy, G.B. Johnson et al. 11C-choline PET/CT in recurrent prostate cancer and nonprostatic neoplastic processes. Radiographics 36, 279–292 (2016)CrossRefPubMed
24.
go back to reference O. Schillaci, F. Calabria, M. Tavolozza, C. Cicciò, M. Carlani, C.R. Caracciolo et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl. Med. Commun. 31, 39–45 (2010)CrossRefPubMed O. Schillaci, F. Calabria, M. Tavolozza, C. Cicciò, M. Carlani, C.R. Caracciolo et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl. Med. Commun. 31, 39–45 (2010)CrossRefPubMed
25.
go back to reference A. Piccardo, M. Massollo, R. Bandelloni, A. Arlandini, L. Foppiani, Lymph node metastasis from tall-cell thyroid cancer negative on 18F-FDG PET/CT and detected by 18F-choline PET/CT. Clin. Nucl. Med. 40, e417–e419 (2015)CrossRefPubMed A. Piccardo, M. Massollo, R. Bandelloni, A. Arlandini, L. Foppiani, Lymph node metastasis from tall-cell thyroid cancer negative on 18F-FDG PET/CT and detected by 18F-choline PET/CT. Clin. Nucl. Med. 40, e417–e419 (2015)CrossRefPubMed
26.
go back to reference J. Jin, C.R. McHenry, Thyroid incidentaloma. Best. Pract. Res. Clin. Endocrinol. Metab. 26, 83–96 (2012)CrossRefPubMed J. Jin, C.R. McHenry, Thyroid incidentaloma. Best. Pract. Res. Clin. Endocrinol. Metab. 26, 83–96 (2012)CrossRefPubMed
27.
go back to reference F. Bertagna, G. Treglia, A. Piccardo, R. Giubbini, Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J. Clin. Endocrinol. Metab. 97, 3866–3875 (2012)CrossRefPubMed F. Bertagna, G. Treglia, A. Piccardo, R. Giubbini, Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J. Clin. Endocrinol. Metab. 97, 3866–3875 (2012)CrossRefPubMed
Metadata
Title
18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer
Authors
Domenico Albano
Rexhep Durmo
Francesco Bertagna
Raffaele Giubbini
Publication date
01-03-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-01832-6

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.